Please assess the completion status of the following clinical trial:

Trial Title: Montelukast in Modulating Exacerbations of Asthma in Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Children aged 2-14 years inclusive~* Doctor-diagnosed asthma~* Needing a beta-agonist inhaler at least once weekly on average for symptom relief~* At least one day lost from school in the past year, or significantly limited activity, because of asthma~* A history of asthma exacerbations associated with apparent respiratory viral infections~* Parent or guardian who is willing to provide informed consent~* Willing to give assent~Exclusion Criteria:~* Non-English speaking~* Unable to understand purpose of study and give consent~* Concomitant respiratory or other major illness e.g. cystic fibrosis, cardiac disease~* Currently using montelukast or other leukotriene receptor antagonist~* Using regular oral corticosteroid~* An asthma exacerbation requiring medical intervention during August 2005

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 14 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).